AP NEWS

Global Traumatic Brain Injury Therapeutics Market 2019-2023| Array of New Drug Approvals to Boost Growth| Technavio

December 26, 2018

LONDON--(BUSINESS WIRE)--Dec 26, 2018-- analysts forecast the global traumatic brain injury therapeutics market to grow at a CAGR of close to 5% during the forecast period, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181226005083/en/

Technavio has published a new market research report on the global traumatic brain injury therapeutics market from 2019-2023. (Graphic: Business Wire)

The increasing awareness of TBI is one of the major trends being witnessed in the . Most of the symptoms of TBI such as problems with speech, dizziness, headache, difficulty in sleeping, nausea, and vomiting, are very common as they are associated with other diseases of brain or CNS. Hence, many times, the disease remains undiagnosed by healthcare practitioners. To overcome this, many organizations across the world are taking initiatives and organizing several programs to increase the awareness of TBI. Such initiatives are expected to boost the growth of the global market.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global traumatic brain injury therapeutics market is the array of new drug approvals.

Global traumatic brain injury therapeutics market: Array of new drug approvals

The number of molecules under development for the treatment of traumatic brain injury is increasing significantly, thanks to the rising prevalence of TBI globally. Most of the therapeutics that are in the last stages of development is expected to get the marketing approval from regulatory authorities such as the US Food and Drug Administration (US FDA) and the European Medicines Agency (EMA) during the forecast. With these drugs expected to be approved, the number of products in the market will increase substantially, driving the growth of the global traumatic brain injury therapeutics market.

According to a senior analyst at Technavio for research on pharmaceuticals, biotechnology & life sciences, “Many companies are forming partnerships to develop and distribute products. Companies form collaborations with various organizations for the distribution of the drugs, spread awareness about the seriousness of the disease, and to help in patient assistance. Such strategic alliances will drive the growth of the market during the forecast period.”

Global traumatic brain injury therapeutics market: Segmentation analysis

The global traumatic brain injury therapeutics market research report provides market segmentation by product (anticonvulsants, anti-anxiety agents, anticoagulants, and analgesics), and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The Americas held the largest share of the market in 2017, accounting for close to 38% share, followed by EMEA and APAC respectively. Although the APAC held the smallest share of the market in 2017, it is expected to register the highest incremental growth during the forecast period.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20181226005083/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 12/26/2018 11:10 AM/DISC: 12/26/2018 11:10 AM

http://www.businesswire.com/news/home/20181226005083/en

AP RADIO
Update hourly